New Results
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
View ORCID ProfileElisabetta Cameroni, Christian Saliba, View ORCID ProfileJohn E. Bowen, View ORCID ProfileLaura E. Rosen, View ORCID ProfileKatja Culap, View ORCID ProfileDora Pinto, View ORCID ProfileAnna De Marco, Samantha K. Zepeda, View ORCID ProfileJulia di Iulio, View ORCID ProfileFabrizia Zatta, View ORCID ProfileHannah Kaiser, Julia Noack, Nisar Farhat, View ORCID ProfileNadine Czudnochowski, View ORCID ProfileColin Havenar-Daughton, View ORCID ProfileKaitlin R. Sprouse, Josh R. Dillen, Abigail E. Powell, Alex Chen, Cyrus Maher, Li Yin, David Sun, View ORCID ProfileLeah Soriaga, View ORCID ProfileClaes Gustafsson, View ORCID ProfileNicholas M. Franko, Jenni Logue, View ORCID ProfileNajeeha Talat Iqbal, Ignacio Mazzitelli, Jorge Geffner, Renata Grifantini, Helen Chu, Andrea Gori, Agostino Riva, Olivier Giannini, View ORCID ProfileAlessandro Ceschi, View ORCID ProfilePaolo Ferrari, View ORCID ProfileAlessandra Franzetti-Pellanda, Christian Garzoni, Christy Hebner, View ORCID ProfileLisa A. Purcell, View ORCID ProfileLuca Piccoli, View ORCID ProfileMatteo Samuele Pizzuto, View ORCID ProfileAlexandra C. Walls, View ORCID ProfileAmalio Telenti, View ORCID ProfileHerbert W. Virgin, View ORCID ProfileAntonio Lanzavecchia, View ORCID ProfileDavid Veesler, Gyorgy Snell, View ORCID ProfileDavide Corti
doi: https://doi.org/10.1101/2021.12.12.472269
Elisabetta Cameroni
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Christian Saliba
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
John E. Bowen
2Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
Laura E. Rosen
3Vir Biotechnology, San Francisco, California 94158, USA
Katja Culap
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Dora Pinto
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Anna De Marco
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Samantha K. Zepeda
2Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
Julia di Iulio
3Vir Biotechnology, San Francisco, California 94158, USA
Fabrizia Zatta
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Hannah Kaiser
3Vir Biotechnology, San Francisco, California 94158, USA
Julia Noack
3Vir Biotechnology, San Francisco, California 94158, USA
Nisar Farhat
3Vir Biotechnology, San Francisco, California 94158, USA
Nadine Czudnochowski
3Vir Biotechnology, San Francisco, California 94158, USA
Colin Havenar-Daughton
3Vir Biotechnology, San Francisco, California 94158, USA
Kaitlin R. Sprouse
2Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
Josh R. Dillen
3Vir Biotechnology, San Francisco, California 94158, USA
Abigail E. Powell
3Vir Biotechnology, San Francisco, California 94158, USA
Alex Chen
3Vir Biotechnology, San Francisco, California 94158, USA
Cyrus Maher
3Vir Biotechnology, San Francisco, California 94158, USA
Li Yin
3Vir Biotechnology, San Francisco, California 94158, USA
David Sun
3Vir Biotechnology, San Francisco, California 94158, USA
Leah Soriaga
3Vir Biotechnology, San Francisco, California 94158, USA
Claes Gustafsson
4ATUM, Newark, California 94560, USA
Nicholas M. Franko
5Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA
Jenni Logue
5Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA
Najeeha Talat Iqbal
6Department of Paediatrics and Child Health, Aga Khan University, Karachi, 74800, Pakistan
Ignacio Mazzitelli
7Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Buenos Aires C1121ABG, Argentina
Jorge Geffner
7Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Buenos Aires C1121ABG, Argentina
Renata Grifantini
8National Institute of Molecular Genetics, Milano, Italy
Helen Chu
5Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA
Andrea Gori
9Infectious Disease Unit, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy
Agostino Riva
10Department of Biomedical and Clinical Sciences ‘L.Sacco’ (DIBIC), Università di Milano, Milan, Italy
Olivier Giannini
11Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland
12Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
Alessandro Ceschi
11Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland
13Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland
14Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Science of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland
15Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
Paolo Ferrari
11Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland
16Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland
17Clinical School, University of New South Wales, Sydney, Australia
Alessandra Franzetti-Pellanda
18Clinical Research Unit, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
Christian Garzoni
19Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland
Christy Hebner
3Vir Biotechnology, San Francisco, California 94158, USA
Lisa A. Purcell
3Vir Biotechnology, San Francisco, California 94158, USA
Luca Piccoli
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Matteo Samuele Pizzuto
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Alexandra C. Walls
2Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
20Howard Hughes Medical Institute, Seattle, WA 98195, USA
Amalio Telenti
2Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
Herbert W. Virgin
3Vir Biotechnology, San Francisco, California 94158, USA
21Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis MO 63110
22Department of Internal Medicine, UT Southwestern Medical Center, Dallas TX 75390
Antonio Lanzavecchia
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
8National Institute of Molecular Genetics, Milano, Italy
David Veesler
2Department of Biochemistry, University of Washington, Seattle, WA 98195, USA
20Howard Hughes Medical Institute, Seattle, WA 98195, USA
Gyorgy Snell
3Vir Biotechnology, San Francisco, California 94158, USA
Davide Corti
1Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
Article usage
Posted December 14, 2021.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, Christian Saliba, John E. Bowen, Laura E. Rosen, Katja Culap, Dora Pinto, Anna De Marco, Samantha K. Zepeda, Julia di Iulio, Fabrizia Zatta, Hannah Kaiser, Julia Noack, Nisar Farhat, Nadine Czudnochowski, Colin Havenar-Daughton, Kaitlin R. Sprouse, Josh R. Dillen, Abigail E. Powell, Alex Chen, Cyrus Maher, Li Yin, David Sun, Leah Soriaga, Claes Gustafsson, Nicholas M. Franko, Jenni Logue, Najeeha Talat Iqbal, Ignacio Mazzitelli, Jorge Geffner, Renata Grifantini, Helen Chu, Andrea Gori, Agostino Riva, Olivier Giannini, Alessandro Ceschi, Paolo Ferrari, Alessandra Franzetti-Pellanda, Christian Garzoni, Christy Hebner, Lisa A. Purcell, Luca Piccoli, Matteo Samuele Pizzuto, Alexandra C. Walls, Amalio Telenti, Herbert W. Virgin, Antonio Lanzavecchia, David Veesler, Gyorgy Snell, Davide Corti
bioRxiv 2021.12.12.472269; doi: https://doi.org/10.1101/2021.12.12.472269
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, Christian Saliba, John E. Bowen, Laura E. Rosen, Katja Culap, Dora Pinto, Anna De Marco, Samantha K. Zepeda, Julia di Iulio, Fabrizia Zatta, Hannah Kaiser, Julia Noack, Nisar Farhat, Nadine Czudnochowski, Colin Havenar-Daughton, Kaitlin R. Sprouse, Josh R. Dillen, Abigail E. Powell, Alex Chen, Cyrus Maher, Li Yin, David Sun, Leah Soriaga, Claes Gustafsson, Nicholas M. Franko, Jenni Logue, Najeeha Talat Iqbal, Ignacio Mazzitelli, Jorge Geffner, Renata Grifantini, Helen Chu, Andrea Gori, Agostino Riva, Olivier Giannini, Alessandro Ceschi, Paolo Ferrari, Alessandra Franzetti-Pellanda, Christian Garzoni, Christy Hebner, Lisa A. Purcell, Luca Piccoli, Matteo Samuele Pizzuto, Alexandra C. Walls, Amalio Telenti, Herbert W. Virgin, Antonio Lanzavecchia, David Veesler, Gyorgy Snell, Davide Corti
bioRxiv 2021.12.12.472269; doi: https://doi.org/10.1101/2021.12.12.472269
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16801)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)